Atogepant (Qulipta®) for migraine prevention
- PMID: 35469689
- DOI: 10.1016/j.tips.2022.03.013
Atogepant (Qulipta®) for migraine prevention
Conflict of interest statement
Declaration of interests D.L.H. and C.S.W. have received research support from Living Cell Technologies and AbbVie. D.L.H. has acted as a consultant or speaker for Amgen, Lilly, and Teva.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical